Clinical trials
Therapy clinical trials
Below are recruiting therapy clinical trials, each written for real people, not researchers. We’re tracking 7,359 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04426461Recruiting
Predicting therapy response for anxiety and depression
This study uses questionnaires (and likely computer tasks) to better predict how you might respond to behavioral therapy for anxiety and depression. If you qualify, your answers help researchers build tools to guide treatment decisions in the future.
Tulsa, OklahomaAges 18–65 - NCT04614961Recruiting
Obesity clinic patient database study
This study collects information about people who visit an obesity clinic. It aims to better understand patients’ health and care needs, which may improve future treatment.
LeuvenAges 18 years+ - NCT04620343Recruiting
Study of breathing treatment for EILO during exercise
This trial tests a treatment approach for exercise-related breathing difficulty called EILO. It aims to help people whose breathing problems show up during peak exercise and who want ongoing follow-up.
Bergen, VestlandAges 12 years+ - NCT04771520RecruitingPhase 2
Avapritinib for tumors with specific KIT or PDGFRA changes
This Phase 2 trial studies avapritinib, a targeted medicine, for people whose cancer has specific KIT or PDGFRA genetic changes. It may help shrink or slow growth of certain advanced cancers, including some brain tumors, when standard treatments have not worked or for specific glioblastoma cases.
Houston, TexasAges 18 years+ - NCT04777656RecruitingPhase 3
Crohn’s exclusion diet plus usual care for kids
This study tests whether a specific “exclusion diet” (removing certain foods) added to standard treatment can better control unstable Crohn’s disease in children. It may help reduce inflammation and flare-ups when symptoms are not controlled by usual medicines.
BronAges 6–17 - NCT04867187Recruiting
Brain stimulation plus mirror therapy for nerve pain
This trial tests whether a noninvasive brain stimulation treatment (repeated TMS) combined with mirror therapy can reduce nerve pain. It may help people whose nerve pain has lasted for months and hasn’t improved enough with usual medicines.
BronAges 18–85 - NCT04892953RecruitingPhase 2
Durvalumab plus focused radiation for progressing stage III lung cancer
This trial studies adding focused radiation to some cancer spots in people with stage III non-small cell lung cancer (NSCLC) whose cancer did not fully stop after standard chemoradiation and durvalumab. The goal is to control a small number of growing spots (or more than a few) and improve outcomes after durvalumab.
Houston, TexasAges 18 years+ - NCT04921137RecruitingPhase 4
Testing benefits and side effects of hormone therapy in older breast cancer patients
This study looks at the potential harms and benefits of hormone (endocrine) therapy in people age 70 and older with early-stage, hormone-receptor–positive breast cancer. It may help doctors choose which hormone treatment approach is safest and most helpful for older patients.
Edmonton, AlbertaAges 70 years+ - NCT07694999Recruiting
Ice packs vs cold baths for heel pain relief
This study compares using ice packs or cold baths along with standard exercises to treat plantar fasciitis, a common cause of heel pain. It aims to see which method works better for reducing pain and improving function.
Peshawar, Khyber PakhtunkhwaAges 18–65 - NCT07319247Enrolling by invitation
Laser therapy and pelvic floor training for stress incontinence
This trial combines laser therapy with pelvic floor muscle exercises to treat stress urinary incontinence (leaking urine when you cough, sneeze, or exercise). It may help strengthen the muscles and tissues that control urine flow, reducing leakage.
Meram, KonyaAges 18–65 - NCT04949360Recruiting
Digital CBT-i program for insomnia using a tablet
This trial tests a phone or tablet app-based program based on CBT-i, a structured therapy that helps improve sleep habits and reduce insomnia symptoms. It may help if you have ongoing insomnia and prefer a digital approach.
São Caetano do Sul, São PauloAges 20–60 - NCT05063136RecruitingPhase 3
Metronomic capecitabine with hormone therapy after breast cancer
This trial studies whether a low-dose “metronomic” chemotherapy medicine (capecitabine) added to standard hormone therapy can reduce breast cancer coming back. It is for people with hormone-receptor–positive, HER2-negative breast cancer after surgery and chemo.
Zhengzhou, HenanAges 18–70 - NCT05111288Recruiting
Testing a pulse field therapy for reduced heart ischemia
This trial studies whether pulse electromagnetic field therapy can improve signs of reduced blood flow to the heart (ischemia) in people who cannot or will not get a coronary procedure during the study. If you already take standard heart medicines, you may be eligible to add this therapy and undergo exercise testing and heart imaging.
Scottsdale, ArizonaAges 18 years+ - NCT05124912Recruiting
Laser treatment for recurrent brain metastases after prior SRS
This study tests whether repeating treatment with a laser (along with a small biopsy) can control brain metastases that have come back after earlier radiation called SRS. It may help people whose cancer is stable enough for surgery and who have a specific, reachable brain spot to target.
Los Angeles, CaliforniaAges 18 years+ - NCT05167656Recruiting
Manual therapy for one-sided jaw pain
This study compares two types of hand-based therapy to see which helps people with jaw (temple/ear-area) pain on one side. You may be eligible if your jaw pain has lasted more than a month and you have not had recent jaw-related treatment or procedures.
Alcalá de Henares, MadridAges 18–75 - NCT05200351Recruiting
Horse-assisted therapy for autistic teens who need more help regulating emotions
This trial tests whether working with horses can improve emotion control in autistic teens who did not get enough benefit from regular therapy. It focuses on safety and making sure participants can understand instructions and interact appropriately with horses.
Ede, GelderlandAges 11–18 - NCT05260177Recruiting
40 Hz light therapy for mild to moderate Alzheimer’s
This study tests whether a non-invasive 40 Hz light therapy system can help people with early Alzheimer’s. You’ll likely use the device at home and wear a small activity monitor, while doing memory and thinking tests.
RoskildeAges 40 years+ - NCT05272488Recruiting
Manual therapy plus vagus nerve stimulation for jaw muscle pain
This trial tests whether combining hands-on jaw treatment with a vagus nerve stimulator can reduce jaw muscle pain and improve jaw movement. It may help people whose jaw pain has been present recently and who have not had recent physiotherapy.
Alcalá de Henares, MadridAges 18 years+ - NCT05292742RecruitingPhase 2
Continue targeted breast cancer therapy or switch to a new combo
This Phase 2 study compares two treatment plans after breast surgery when cancer did not fully disappear before surgery. It tests whether adding trastuzumab, pyrotinib, and capecitabine works better than continuing the original targeted therapy.
Fuzhou, FujianAges 18–75 - NCT05352178RecruitingPhase 3
Targeted treatment for few-spread prostate cancer spots
This Phase 3 trial tests whether treating only a small number of prostate cancer metastases can help people with “oligorecurrent” (limited repeat) prostate cancer. It may reduce cancer activity while avoiding broader whole-body treatment for some patients.
LeuvenAges 18 years+ - NCT05371132RecruitingPhase 1
PET scan study to track immune response after SBRT
This early (Phase 1) study uses a special PET scan to measure how your immune system responds after stereotactic body radiation therapy (SBRT). The goal is to see whether the scan result can serve as a marker of immune response, which may help future treatment planning.
Duarte, CaliforniaAges 18 years+ - NCT05406856Recruiting
Adaptive proton therapy for cervical cancer with chemo
This trial tests whether an “adaptive” type of radiation planning using proton therapy and MRI-guided brachytherapy can improve treatment for people with cervical cancer. It aims to deliver curative treatment more precisely while still combining it with chemotherapy (cisplatin) when appropriate.
LeidenAges 18 years+ - NCT05419934Recruiting
EMDR therapy for young children with stress and anxiety
This study tests whether EMDR therapy (a structured way to help process distressing experiences) helps children ages 3 to 6 who have symptoms related to trauma, stress, or anxiety. You’d be randomly assigned to receive the study therapy or a comparison condition, and researchers would track outcomes.
NiceAges 3–6 - NCT05434637Recruiting
Study for constant tinnitus using head and jaw maneuvers
This trial tests whether a treatment approach can change your tinnitus by using movements of your head, neck, and/or jaw. It may help people whose tinnitus can be temporarily reduced or changed by these maneuvers.
Portland, OregonAges 18 years+
Hear when a new Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for therapy?
- Yes. Clin2 currently lists 7,359 recruiting therapy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a therapy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a therapy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.